These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 35501858)

  • 1. Involvement of IL-26 in bronchiolitis obliterans syndrome but not in acute rejection after lung transplantation.
    Magnusson JM; Ericson P; Tengvall S; Stockfelt M; Brundin B; Lindén A; Riise GC
    Respir Res; 2022 May; 23(1):108. PubMed ID: 35501858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of induced sputum and bronchoalveolar lavage in lung transplant recipients.
    Mamessier E; Milhe F; Badier M; Thomas P; Magnan A; Reynaud-Gaubert M
    J Heart Lung Transplant; 2006 May; 25(5):523-32. PubMed ID: 16678030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Persistent high BAL fluid granulocyte activation marker levels as early indicators of bronchiolitis obliterans after lung transplant.
    Riise GC; Andersson BA; Kjellström C; Martensson G; Nilsson FN; Ryd W; Scherstén H
    Eur Respir J; 1999 Nov; 14(5):1123-30. PubMed ID: 10596701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Airway neutrophilia in stable and bronchiolitis obliterans syndrome patients following lung transplantation.
    Zheng L; Walters EH; Ward C; Wang N; Orsida B; Whitford H; Williams TJ; Kotsimbos T; Snell GI
    Thorax; 2000 Jan; 55(1):53-9. PubMed ID: 10607802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased serum and bronchoalveolar lavage levels of Clara cell secretory protein (CC16) is associated with bronchiolitis obliterans syndrome and airway neutrophilia in lung transplant recipients.
    Nord M; Schubert K; Cassel TN; Andersson O; Riise GC
    Transplantation; 2002 Apr; 73(8):1264-9. PubMed ID: 11981419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The presence of a matrix-derived neutrophil chemoattractant in bronchiolitis obliterans syndrome after lung transplantation.
    Hardison MT; Galin FS; Calderon CE; Djekic UV; Parker SB; Wille KM; Jackson PL; Oster RA; Young KR; Blalock JE; Gaggar A
    J Immunol; 2009 Apr; 182(7):4423-31. PubMed ID: 19299743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bronchiolitis obliterans syndrome in lung transplant recipients is associated with increased neutrophil activity and decreased antioxidant status in the lung.
    Riise GC; Williams A; Kjellström C; Schersten H; Andersson BA; Kelly FJ
    Eur Respir J; 1998 Jul; 12(1):82-8. PubMed ID: 9701419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aspiration, localized pulmonary inflammation, and predictors of early-onset bronchiolitis obliterans syndrome after lung transplantation.
    Fisichella PM; Davis CS; Lowery E; Ramirez L; Gamelli RL; Kovacs EJ
    J Am Coll Surg; 2013 Jul; 217(1):90-100; discussion 100-1. PubMed ID: 23628225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-1 receptor antagonist as a biomarker for bronchiolitis obliterans syndrome in lung transplant recipients.
    Belperio JA; DiGiovine B; Keane MP; Burdick MD; Ying Xue Y; Ross DJ; Lynch JP; Kunkel SL; Strieter RM
    Transplantation; 2002 Feb; 73(4):591-9. PubMed ID: 11889437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical utility of bronchoalveolar lavage cell phenotype analyses in the postoperative monitoring of lung transplant recipients.
    Reynaud-Gaubert M; Thomas P; Gregoire R; Badier M; Cau P; Sampol J; Giudicelli R; Fuentes P
    Eur J Cardiothorac Surg; 2002 Jan; 21(1):60-6. PubMed ID: 11788258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bronchoalveolar lavage fluid characteristics in acute and chronic lung transplant rejection.
    Slebos DJ; Postma DS; Koëter GH; Van Der Bij W; Boezen M; Kauffman HF
    J Heart Lung Transplant; 2004 May; 23(5):532-40. PubMed ID: 15135367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upregulation of chemokines in bronchoalveolar lavage fluid as a predictive marker of post-transplant airway obliteration.
    Reynaud-Gaubert M; Marin V; Thirion X; Farnarier C; Thomas P; Badier M; Bongrand P; Giudicelli R; Fuentes P
    J Heart Lung Transplant; 2002 Jul; 21(7):721-30. PubMed ID: 12100898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of bronchoalveolar lavage neutrophilia in stable lung transplant recipients.
    Neurohr C; Huppmann P; Samweber B; Leuschner S; Zimmermann G; Leuchte H; Baumgartner R; Hatz R; Frey L; Ueberfuhr P; Bittmann I; Behr J;
    J Heart Lung Transplant; 2009 May; 28(5):468-74. PubMed ID: 19416775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mesenchymal stromal cells in bronchoalveolar lavage as predictors of bronchiolitis obliterans syndrome.
    Badri L; Murray S; Liu LX; Walker NM; Flint A; Wadhwa A; Chan KM; Toews GB; Pinsky DJ; Martinez FJ; Lama VN
    Am J Respir Crit Care Med; 2011 Apr; 183(8):1062-70. PubMed ID: 21169468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alveolar neutrophilia is a predictor for the bronchiolitis obliterans syndrome, and increases with degree of severity.
    Devouassoux G; Drouet C; Pin I; Brambilla C; Brambilla E; Colle PE; Pison C;
    Transpl Immunol; 2002 Nov; 10(4):303-10. PubMed ID: 12507402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pretransplant serum human chitinase-like glycoprotein YKL-40 concentrations independently predict bronchiolitis obliterans development in lung transplant recipients.
    Jaksch P; Taghavi S; Klepetko W; Salama M
    J Thorac Cardiovasc Surg; 2014 Jul; 148(1):273-81. PubMed ID: 24685381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Broncho-alveolar lavage matrix metalloproteases as a sensitive measure of bronchiolitis obliterans.
    Taghavi S; Krenn K; Jaksch P; Klepetko W; Aharinejad S
    Am J Transplant; 2005 Jun; 5(6):1548-52. PubMed ID: 15888067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bronchoalveolar lavage cytokine profile in a cohort of lung transplant recipients: a predictive role of interleukin-12 with respect to onset of bronchiolitis obliterans syndrome.
    Meloni F; Vitulo P; Cascina A; Oggionni T; Bulgheroni A; Paschetto E; Klersy C; D'Armini AM; Fietta A; Bianco AM; Arbustini E; Viganò M
    J Heart Lung Transplant; 2004 Sep; 23(9):1053-60. PubMed ID: 15454171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased percentage of CD4+FoxP3+ cells in bronchoalveolar lavage from lung transplant recipients correlates with development of bronchiolitis obliterans syndrome.
    Bhorade SM; Chen H; Molinero L; Liao C; Garrity ER; Vigneswaran WT; Shilling R; Sperling A; Chong A; Alegre ML
    Transplantation; 2010 Sep; 90(5):540-6. PubMed ID: 20628341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bronchiolitis obliterans syndrome and restrictive allograft syndrome: do risk factors differ?
    Verleden SE; Ruttens D; Vandermeulen E; Vaneylen A; Dupont LJ; Van Raemdonck DE; Verleden GM; Vanaudenaerde BM; Vos R
    Transplantation; 2013 May; 95(9):1167-72. PubMed ID: 23425818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.